HomeRNAZ • NASDAQ
add
Transcode Therapeutics Inc
Previous close
$8.64
Day range
$8.45 - $9.00
Year range
$6.15 - $468.44
Market cap
7.89M USD
Avg Volume
12.91K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.56M | 110.64% |
Net income | -4.86M | -109.19% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.56M | -111.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.84M | 51.18% |
Total assets | 5.23M | 32.79% |
Total liabilities | 3.80M | 66.41% |
Total equity | 1.43M | — |
Shares outstanding | 916.97K | — |
Price to book | 5.05 | — |
Return on assets | -169.02% | — |
Return on capital | -301.12% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -4.86M | -109.19% |
Cash from operations | -4.08M | -4.36% |
Cash from investing | — | — |
Cash from financing | -455.73K | -118.63% |
Net change in cash | -4.54M | -206.95% |
Free cash flow | -2.36M | 18.30% |
About
Founded
2016
Headquarters
Website
Employees
7
